A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain

COVID-19 has emerged, and has rapidly become a major health problem worldwide, causing millions of mortalities. Vaccination against COVID-19 is the most efficient way to stop the pandemic. The goal of vaccines is to induce neutralizing antibodies against SARS-CoV-2 virus. Here, we present a novel do...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xinyue Chang, Andris Zeltins, Mona O. Mohsen, Zahra Gharailoo, Lisha Zha, Xuelan Liu, Senta Walton, Monique Vogel, Martin F. Bachmann
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID19
SARS-CoV-2
vaccine
virus-like particle
CuMV<sub>TT</sub>-DF
Medicine
R
Acceso en línea:https://doaj.org/article/d8938000f77d420cb0d46092de4bfad9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/d8938000f77d420cb0d46092de4bfad9

Ejemplares similares